Improving Surgeon Performance Measures for Robot-Assisted Surgery
Generalized Robotic Skills Assessment Using Machine Learning-Based Analysis Across Multiple Surgical Specialties
1 other identifier
observational
1,000
1 country
7
Brief Summary
The purpose of this study is to develop new tools to understand surgeon performance to improve surgical training and participant outcomes after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2023
Typical duration for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2023
CompletedFirst Submitted
Initial submission to the registry
August 25, 2023
CompletedFirst Posted
Study publicly available on registry
September 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 24, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 24, 2026
May 21, 2025
May 1, 2025
3 years
August 25, 2023
May 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation of Automated Performance Metrics to surgeon experience
For the primary objective, we will capture Automated Performance Metrics/APMs and will determine the association between these and other metrics and surgeon experience, which will be used to construct validation. APMs that will be used in the study: Time Metrics Camera Metrics Instrument Metrics System Metrics Articulation Metrics
Up to 2 years
Study Arms (1)
Robotic surgeons
Participants will be robotic surgeons in urologic, gynecologic, colorectal, hepatobiliary, gastric, and thoracic surgery
Interventions
Surgeons will perform and participants will undergo robotic surgery according to the standard of care. No additional interventions will be performed on participating participants.
Eligibility Criteria
Surgeons who meet the inclusion criteria will be approached by the study team for participation in this study.
You may qualify if:
- Surgeons who perform robotic surgery for candidate procedures
- Surgeons who perform candidate procedures that are frequently performed by at least three surgeons (to ensure the ability to make adequate comparisons)
- Surgeons who agree to participate in the study
You may not qualify if:
- Surgeons who decline to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey, 07920, United States
Memorial Sloan Kettering Monmouth (Limited protocol activities)
Middletown, New Jersey, 07748, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey, 07645, United States
Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities )
Commack, New York, 11725, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, New York, 10604, United States
Memorial Sloan Kettering Cancer Center (All protocol activites)
New York, New York, 10065, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activites)
Rockville Centre, New York, 11553, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alvin Goh, MD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2023
First Posted
September 14, 2023
Study Start
August 24, 2023
Primary Completion (Estimated)
August 24, 2026
Study Completion (Estimated)
August 24, 2026
Last Updated
May 21, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made following one year after publication and for up to 36 months later. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.